Skip to main content
Clinical Trials/JPRN-UMIN000039474
JPRN-UMIN000039474
Completed
Phase 3

Single-arm study for assessment of safety and effectiveness of the ultracompact extracorporeal membrane oxygenation (ECMO) system (BR13030) use as a long-term cardiopulmonary support for severe heart and/or respiratory failure: study protocol for multiple-center, single-arm non-randomized, uncontrolled, and investigator-initiated clinical trial. - Single-arm study for assessment of safety and effectiveness of the ultracompact extracorporeal membrane oxygenation (ECMO) system (BR13030) use as a long-term cardiopulmonary support for severe heart and/or respiratory failure: study protocol for multiple-center, single-arm non-randomized, uncontrolled, and investigator-initiated clinical trial.

ational Cerebral and Cardiovascular Center0 sites25 target enrollmentFebruary 17, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Cerebral and Cardiovascular Center
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2020
End Date
December 17, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Cerebral and Cardiovascular Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Unfavorable or technically\-challenging cardiac anatomy 2\) Evidence of irreversible hepatic disease (except when the primary investigator deems it as a sign of acute heart failure) 3\) Evidence of irreversible renal disease (except when the primary investigator deems it as a sign of acute heart failure) 4\) Contraindicated for anticoagulation 5\) Difficulty of 14\-day observation is anticipated 6\) Participating in another clinical trial at time of study entry 7\) Deemed unsuitable by the primary investigator for other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials